Signal active
Contact Information
Social
Primary Organization
2007
51-100
Biotechnology, Health Care, Therapeutics
Bio
Before joining Crescendo, Pavel was the Head of Translational Medicine at Roche and Genentech where he led over 50 programs through early and late clinical development. As both a physician and a scientist, he has in-depth knowledge of the real-life experimental and clinical challenges associated with delivering highly innovative medicines and has successfully translated scientific findings into transformative medicines such as Avastin and Gazyva, leading to significant improvement in the lives of cancer patients.
Pavel has a distinguished academic, clinical and scientific career at world-leading medical institutions. He was Professor of Clinical Experimental Oncology at the Karolinska Institutet, Stockholm and has held positions at NIH, MD Anderson Cancer Center and Scripps Research Institute. He is the author of 115 highly-cited publications and patents within tumour immunology. Pavel holds a medical degree and a doctorate in medicine in Natural Killer Cells in the clinic from Charles University, Prague, as well as a PhD in Immunology from the Karolinska Institutet.
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Pavel Pisa is the CMO at Crescendo Biologics, based in Europe. With a background in Biotechnology, Pavel Pisa has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.